.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Moodys
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Argus Health
Dow
Healthtrust
UBS
Chubb

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,741,358

« Back to Dashboard

Which drugs does patent 7,741,358 protect, and when does it expire?


Patent 7,741,358 protects SAPHRIS and is included in one NDA. There has been one Paragraph IV challenge on Saphris.

Protection for SAPHRIS has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 7,741,358

Title:Crystal form of asenapine maleate
Abstract:The invention relates to an orthorhombic crystal form of compound trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz [2,3:6,7]oxepino[4,5-c]pyrrole (Z)-2-butenedioate, to methods for the preparation of this crystal form and to pharmaceutical compositions comprising an orthorhombic crystal form.
Inventor(s): Heeres; Gerhardus Johannes (Oss, NL)
Assignee: N.V. Organon (Oss, NL)
Application Number:11/399,204
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Forest Labs Llc
SAPHRIS
asenapine maleate
TABLET;SUBLINGUAL022117-003Mar 12, 2015RXYesNo7,741,358*PED► SubscribeY
Forest Labs Llc
SAPHRIS
asenapine maleate
TABLET;SUBLINGUAL022117-001Aug 13, 2009RXYesNo7,741,358*PED► SubscribeY
Forest Labs Llc
SAPHRIS
asenapine maleate
TABLET;SUBLINGUAL022117-002Aug 13, 2009RXYesYes7,741,358*PED► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKinsey
Chubb
Deloitte
Farmers Insurance
QuintilesIMS
Queensland Health
US Army
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot